Home
CELU
CELU News

Latest Celularity Inc. (CELU) News on October 18, 2025

GlobeNewswire

4 days ago

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

Celularity Announces Chief Financial Officer Transition

GlobeNewswire

4 months ago

Celularity Announces Chief Financial Officer Transition

GlobeNewswire

5 months ago

Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology

GlobeNewswire

5 months ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q

GlobeNewswire

5 months ago

Celularity Announces Full Year 2024 Operating and Financial Results

GlobeNewswire

6 months ago

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

GlobeNewswire

6 months ago

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

GlobeNewswire

6 months ago

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology

GlobeNewswire

8 months ago

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

GlobeNewswire

8 months ago

Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

GlobeNewswire

9 months ago

MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs

GlobeNewswire

10 months ago

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

GlobeNewswire

10 months ago

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

GlobeNewswire

a year ago

Celularity Inc. Announces Receipt of Nasdaq Notification

GlobeNewswire

a year ago

Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific

GlobeNewswire

a year ago

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

GlobeNewswire

a year ago

Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million

GlobeNewswire

a year ago

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel

GlobeNewswire

a year ago

Celularity Provides Corporate Update

GlobeNewswire

a year ago

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

GlobeNewswire

a year ago

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.

GlobeNewswire

a year ago

Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Celularity Appoints Richard J. Berman to its Board of Directors

GlobeNewswire

a year ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

GlobeNewswire

a year ago

Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

GlobeNewswire

a year ago

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

a year ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

GlobeNewswire

a year ago

Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy

GlobeNewswire

a year ago

Celularity Inc. to Host Investor and Analyst Research & Development Day

GlobeNewswire

a year ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

GlobeNewswire

a year ago

Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024

GlobeNewswire

2 years ago

Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products

GlobeNewswire

2 years ago

Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells

GlobeNewswire

2 years ago

Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L

GlobeNewswire

2 years ago

Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy

GlobeNewswire

2 years ago

Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit

GlobeNewswire

2 years ago

Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress

Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells

GlobeNewswire

2 years ago

Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells

Celularity Announces 1-for-10 Reverse Stock Split

GlobeNewswire

2 years ago

Celularity Announces 1-for-10 Reverse Stock Split

Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease

GlobeNewswire

2 years ago

Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease

Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline

GlobeNewswire

2 years ago

Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline

Public companies account for 60% of trivago N.V.'s (NASDAQ:TRVG) ownership, while insiders account for 22%

Simply Wall St.

2 years ago

Public companies account for 60% of trivago N.V.'s (NASDAQ:TRVG) ownership, while insiders account for 22%

Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion

GlobeNewswire

2 years ago

Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion

Is Weakness In Daktronics, Inc. (NASDAQ:DAKT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Simply Wall St.

2 years ago

Is Weakness In Daktronics, Inc. (NASDAQ:DAKT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Natural Gas Services Group, Inc. (NYSE:NGS) is favoured by institutional owners who hold 52% of the company

Simply Wall St.

2 years ago

Natural Gas Services Group, Inc. (NYSE:NGS) is favoured by institutional owners who hold 52% of the company

Chuck Royce's Firm Adjusts Position in Orion Group Holdings Inc

GuruFocus.com

2 years ago

Chuck Royce's Firm Adjusts Position in Orion Group Holdings Inc

BCB Bancorp (BCBP) Misses Q4 Earnings and Revenue Estimates

Zacks

2 years ago

BCB Bancorp (BCBP) Misses Q4 Earnings and Revenue Estimates

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

GlobeNewswire

2 years ago

Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions

Associated Press Finance

2 years ago

BCB Bancorp: Q4 Earnings Snapshot

BCB Bancorp, Inc. Earns $6.1 Million in Fourth Quarter 2023; Reports $0.35 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share

GlobeNewswire

2 years ago

BCB Bancorp, Inc. Earns $6.1 Million in Fourth Quarter 2023; Reports $0.35 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share

trivago N.V.'s Fourth Quarter 2023 Earnings Release Scheduled for February 6, 2024; Webcast Scheduled for February 7, 2024

GlobeNewswire

2 years ago

trivago N.V.'s Fourth Quarter 2023 Earnings Release Scheduled for February 6, 2024; Webcast Scheduled for February 7, 2024

Chuck Royce's Firm Reduces Stake in AstroNova Inc

GuruFocus.com

2 years ago

Chuck Royce's Firm Reduces Stake in AstroNova Inc

Celularity Releases CEO Letter to Shareholders

GlobeNewswire

2 years ago

Celularity Releases CEO Letter to Shareholders

AstroNova Updates Upcoming Investor Conference Schedule

Business Wire

2 years ago

AstroNova Updates Upcoming Investor Conference Schedule

Here’s How AstroNova’s (ALOT) Intrinsic Value Increased Significantly

Insider Monkey

2 years ago

Here’s How AstroNova’s (ALOT) Intrinsic Value Increased Significantly

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

AstroNova to Present at Upcoming Investor Conferences

Business Wire

2 years ago

AstroNova to Present at Upcoming Investor Conferences

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

GlobeNewswire

2 years ago

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

GlobeNewswire

2 years ago

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023

GlobeNewswire

2 years ago

Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023

Business Wire

2 years ago

Special Opportunities Fund Declares Distributions For First Quarter of 2024

Idaho Strategic Provides 2023 Year in Review

ACCESSWIRE

2 years ago

Idaho Strategic Provides 2023 Year in Review

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 years ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Invesco Closed-End Funds Declare Dividends

PR Newswire

2 years ago

Invesco Closed-End Funds Declare Dividends

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?

Simply Wall St.

2 years ago

Can Mixed Fundamentals Have A Negative Impact on AstroNova, Inc. (NASDAQ:ALOT) Current Share Price Momentum?

Reuters

2 years ago

Israeli food importer G. Willi warns of delays, higher costs from Red Sea attacks

G. Willi-Food international reports the results of THIRD quarter 2023

PR Newswire

2 years ago

G. Willi-Food international reports the results of THIRD quarter 2023

Reuters

2 years ago

UPDATE 1-Aldeyra Therapeutics' skin disease drug succeeds in mid-stage study

3 Russell 2000 Stocks That Are About to Get Absolutely Crushed

InvestorPlace

2 years ago

3 Russell 2000 Stocks That Are About to Get Absolutely Crushed

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Simply Wall St.

2 years ago

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

GlobeNewswire

2 years ago

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

Business Wire

2 years ago

Special Opportunities Fund, Inc. Dividend Declaration

AstroNova, Inc. (NASDAQ:ALOT) Q3 2024 Earnings Call Transcript

Insider Monkey

2 years ago

AstroNova, Inc. (NASDAQ:ALOT) Q3 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2024 AstroNova Inc Earnings Call

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

GlobeNewswire

2 years ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Virtus Stone Harbor Emerging Markets Total Income Fund Provides Update on Reorganization and Announces Monthly Distribution

Business Wire

2 years ago

Virtus Stone Harbor Emerging Markets Total Income Fund Provides Update on Reorganization and Announces Monthly Distribution

Business Wire

2 years ago

Special Opportunities Fund, Inc. Annual Stockholders Meeting

USCB Financial Holdings, Inc. Announces Retirement of Chief Credit Officer, Benigno Pazos; Announces the Departure of Jay Shehadeh, General Counsel; Promotes Maricarmen Logroño to Chief Risk Officer

GlobeNewswire

2 years ago

USCB Financial Holdings, Inc. Announces Retirement of Chief Credit Officer, Benigno Pazos; Announces the Departure of Jay Shehadeh, General Counsel; Promotes Maricarmen Logroño to Chief Risk Officer

Share on Social Networks: